Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
MA
|
Foundation Mastercard |
SELL
Open market or private sale
|
Direct | 57,198 Reduced 0.05% |
$19,037,782
$332.84 p/Share
|
Feb 03
2021 |
|
META
|
Mark Zuckerberg
COB and CEO |
SELL
Open market or private sale
|
Indirect | 44,750 Reduced 32.74% |
$11,937,510
$266.76 p/Share
|
Feb 03
2021 |
|
FIBK
|
Jeremy Scott
Director |
SELL
Open market or private sale
|
Indirect | 10,223 Reduced 10.69% |
$409,022
$40.01 p/Share
|
Feb 03
2021 |
|
FIBK
|
Susan Scott Heyneman
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 17.57% |
$1,197,000
$39.9 p/Share
|
Feb 03
2021 |
|
TVTX
|
Noah L. Rosenberg
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 1,813 Reduced 3.95% |
$52,414
$28.91 p/Share
|
Feb 03
2021 |
|
TVTX
|
William E. Rote
Chief Research Officer |
SELL
Open market or private sale
|
Direct | 3,625 Reduced 8.85% |
$104,799
$28.91 p/Share
|
Feb 03
2021 |
|
TVTX
|
Elizabeth E Reed
Chief Legal Officer and GC |
SELL
Open market or private sale
|
Direct | 3,175 Reduced 7.77% |
$91,789
$28.91 p/Share
|
Feb 03
2021 |
|
TVTX
|
Laura Clague
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,625 Reduced 10.11% |
$104,799
$28.91 p/Share
|
Feb 03
2021 |
|
TVTX
|
Eric M Dube
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 2,406 Reduced 1.59% |
$69,557
$28.91 p/Share
|
Feb 03
2021 |
|
AMK
|
Natalie Grace Wolfsen
EVP, Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 22,846 Reduced 6.35% |
$526,143
$23.03 p/Share
|
Feb 03
2021 |
|
BMRC
|
Elizabeth Reizman
Executive Vice President |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 3.74% |
$37,640
$37.64 p/Share
|
Feb 03
2021 |
|
FLWS
|
Thomas G Hartnett |
SELL
Open market or private sale
|
Direct | 20,759 Reduced 11.25% |
$622,978
$30.01 p/Share
|
Feb 03
2021 |
|
SPRO
|
Aquilo Capital Management, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 29,354 Reduced 0.75% |
$557,139
$18.98 p/Share
|
Feb 03
2021 |
|
MRNA
|
Stephen Hoge
President |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.61% |
$1,565,100
$156.51 p/Share
|
Feb 03
2021 |
|
PCVX
|
Robert Lorne Hopfner
Director |
SELL
Open market or private sale
|
Indirect | 2,768 Reduced 0.15% |
$69,366
$25.06 p/Share
|
Feb 03
2021 |
|
HGEN
|
Nomis Bay Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 0.42% |
$480,750
$19.23 p/Share
|
Feb 03
2021 |
|
TXN
|
Richard K Templeton
Chairman |
SELL
Open market or private sale
|
Direct | 112,500 Reduced 18.08% |
$19,351,124
$172.01 p/Share
|
Feb 03
2021 |
|
HARP
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect | 41,922 Reduced 1.17% |
$847,244
$20.21 p/Share
|
Feb 03
2021 |
|
RFM
|
Rivernorth Capital Management, LLC |
SELL
Open market or private sale
|
Direct | 3,662 Reduced 1.37% |
$81,736
$22.32 p/Share
|
Feb 03
2021 |
|
RIV
|
Rivernorth Capital Management, LLC |
SELL
Open market or private sale
|
Direct | 7,459 Reduced 6.11% |
$126,878
$17.01 p/Share
|
Feb 03
2021 |
|
AGBAR
|
Glazer Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 26,200 Reduced 4.21% |
$274,314
$10.47 p/Share
|
Feb 03
2021 |
|
STAA
|
Broadwood Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 10,585 Reduced 0.11% |
$1,169,007
$110.44 p/Share
|
Feb 03
2021 |
|
STAA
|
Broadwood Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 0 Reduced 0.0% |
-
|
Feb 03
2021 |
|
DELL
|
Jeffrey W Clarke
COO & Vice Chairman |
SELL
Open market or private sale
|
Direct | 13,946 Reduced 3.5% |
$1,070,356
$76.75 p/Share
|
Feb 03
2021 |
|
PCAR
|
T. Kyle Quinn
SR. V.P. & CHIEF TECH. OFFICER |
SELL
Open market or private sale
|
Direct | 24,516 Reduced 47.0% |
$2,336,130
$95.29 p/Share
|
Feb 03
2021 |
|
PCAR
|
Todd R Hubbard
VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 72.94% |
$190,000
$95.0 p/Share
|
Feb 03
2021 |
|
IBKR
|
Thomas Peterffy
Chairman |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.22% |
$1,371,200
$68.56 p/Share
|
Feb 03
2021 |
|
UMBF
|
J Mariner Kemper
Chairman and CEO |
SELL
Open market or private sale
|
Direct | 2,939 Reduced 1.49% |
$215,282
$73.25 p/Share
|
Feb 03
2021 |
|
PCRX
|
David M Stack
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 21,250 Reduced 21.84% |
$1,510,875
$71.1 p/Share
|
Feb 03
2021 |
|
MTOR
|
Chris Villavarayan
CEO & President |
SELL
Open market or private sale
|
Direct | 601 Reduced 1.37% |
$18,913
$31.47 p/Share
|
Feb 03
2021 |
|
MTOR
|
Paul Bialy
VP & CAO (PAO) |
SELL
Open market or private sale
|
Direct | 140 Reduced 0.49% |
$4,283
$30.59 p/Share
|
Feb 03
2021 |
|
MORF
|
Omega Fund V, L.P.
Director |
SELL
Open market or private sale
|
Direct | 26,158 Reduced 0.96% |
$1,002,898
$38.34 p/Share
|
Feb 03
2021 |
|
HMST
|
Godfrey B Evans
EVP - General Counsel |
SELL
Open market or private sale
|
Direct | 14,000 Reduced 18.17% |
$536,760
$38.34 p/Share
|
Feb 03
2021 |
|
NKTR
|
Howard W Robin
President & CEO |
SELL
Open market or private sale
|
Direct | 150,000 Reduced 24.64% |
$2,958,000
$19.72 p/Share
|
Feb 03
2021 |
|
NKTR
|
Gil M Labrucherie
SVP, COO & CFO |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 15.77% |
$980,500
$19.61 p/Share
|
Feb 03
2021 |
|
IGMS
|
Bruce Keyt
CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct | 1,619 Reduced 36.9% |
$155,424
$96.0 p/Share
|
Feb 03
2021 |
|
IGMS
|
Daniel Shin Yu Chen
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 1,226 Reduced 1.04% |
$117,696
$96.0 p/Share
|
Feb 03
2021 |
|
RLMD
|
Sergio Traversa
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 100 Reduced 0.11% |
$3,500
$35.0 p/Share
|
Feb 03
2021 |
|
RLMD
|
Maged Shenouda
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 100 Reduced 4.3% |
$3,500
$35.0 p/Share
|
Feb 03
2021 |
|
MCS
|
Gregory S Marcus
President and CEO |
SELL
Open market or private sale
|
Direct | 12,027 Reduced 5.68% |
$211,555
$17.59 p/Share
|
Feb 03
2021 |
|
PNTG
|
Daniel H Walker
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 7,647 Reduced 0.69% |
$420,509
$54.99 p/Share
|
Feb 03
2021 |
|
RIDE
|
Phil Richard Schmidt
PRESIDENT |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 84.22% |
$1,372,000
$27.44 p/Share
|
Feb 03
2021 |
|
VRA
|
Patricia R. Miller |
SELL
Open market or private sale
|
Indirect | 152,499 Reduced 8.47% |
$1,326,741
$8.7 p/Share
|
Feb 03
2021 |
|
VRA
|
P. Michael Miller |
SELL
Open market or private sale
|
Indirect | 152,499 Reduced 8.47% |
$1,326,741
$8.7 p/Share
|
Feb 03
2021 |
|
STRT
|
Richard P Messina
VP & Chief Technical Officer |
SELL
Open market or private sale
|
Direct | 6,112 Reduced 37.61% |
$342,333
$56.01 p/Share
|
Feb 03
2021 |
|
STRT
|
Rolando Guillot
SVP & COO |
SELL
Open market or private sale
|
Direct | 1,300 Reduced 6.21% |
$72,813
$56.01 p/Share
|
Feb 03
2021 |
|
PFIN
|
Lawndale Capital Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 1,200 Reduced 0.35% |
$7,692
$6.41 p/Share
|
Feb 03
2021 |
|
PFIN
|
Diamond A Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 1,200 Reduced 0.35% |
$7,692
$6.41 p/Share
|
Feb 03
2021 |
|
PLAN
|
Sandesh Kaveripatnam
Director |
SELL
Open market or private sale
|
Direct | 3,452 Reduced 4.95% |
$261,938
$75.88 p/Share
|
Feb 03
2021 |
|
ACN
|
David Rowland
Executive Chairman |
SELL
Open market or private sale
|
Direct | 7,966 Reduced 99.5% |
$1,980,348
$248.6 p/Share
|
Feb 03
2021 |